High-capacity adenoviral vectors for gene transfer and somatic gene therapy

被引：136

作者：

Kochanek, S ^{[1
]}

机构：

[1] Univ Cologne, Ctr Mol Med, D-50931 Cologne, Germany

来源：

HUMAN GENE THERAPY | 1999年 / 10卷 / 15期

关键词：

D O I：

10.1089/10430349950016807

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

The availability of efficient and nontoxic gene delivery technologies is fundamental to the translation of therapeutic concepts into clinical practice by gene transfer. High-capacity adenoviral (HC-Ad) vectors are characterized by the ability to transduce cells in vitro and in vivo with more than 30 kb of nonviral DNA, This quality allows simultaneous gene transfer of several expression cassettes, large promoters, and some genes in their natural genomic context. Because all viral coding sequences are removed from these vectors, safety is considerably improved compared with previous-generation adenoviral vectors.

引用

页码：2451 / 2459

页数：9

共 65 条

[41] In vitro and in vivo biology of recombinant adenovirus vectors with E1, E1/E2A, or E1/E4 deleted
Lusky, M
Christ, M
Rittner, K
Dieterle, A
Dreyer, D
Mourot, B
Schultz, H
Stoeckel, F
Pavirani, A
Mehtali, M
[J]. JOURNAL OF VIROLOGY, 1998, 72 (03) : 2022 - 2032
[42] AN ADENOVIRUS VECTOR SYSTEM USED TO EXPRESS POLYOMA-VIRUS TUMOR-ANTIGENS
MANSOUR, SL
GRODZICKER, T
TJIAN, R
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (05) : 1359 - 1363
[43] Adenovirus-mediated gene transfer: Influence of transgene, mouse strain and type of immune response on persistence of transgene expression
Michou, AI
Santoro, L
Christ, M
Julliard, V
Pavirani, A
Mehtali, M
[J]. GENE THERAPY, 1997, 4 (05) : 473 - 482
[44] RESCUE, PROPAGATION, AND PARTIAL-PURIFICATION OF A HELPER VIRUS-DEPENDENT ADENOVIRUS VECTOR
MITANI, K
GRAHAM, FL
CASKEY, CT
KOCHANEK, S
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (09) : 3854 - 3858
[45] Immune responses to reporter proteins and high viral dose limit duration of expression with adenoviral vectors: Comparison of E2a wild type and E2a deleted vectors
Morral, N
ONeal, W
Zhou, HS
Langston, C
Beaudet, A
[J]. HUMAN GENE THERAPY, 1997, 8 (10) : 1275 - 1286
[46] High doses of a helper-dependent adenoviral vector yield supraphysiological levels of α1-antitrypsin with negligible toxicity
Morral, N
Parks, RJ
Zhou, HS
Langston, C
Schiedner, G
Quinones, J
Graham, FL
Kochanek, S
Beaudet, AL
[J]. HUMAN GENE THERAPY, 1998, 9 (18) : 2709 - 2716
[47] An adenoviral vector deleted for all viral coding sequences results in enhanced safety and extended expression of a leptin transgene
Morsy, MA
Gu, MC
Motzel, S
Zhao, J
Su, Q
Allen, H
Franlin, L
Parks, RJ
Graham, FL
Kochanek, S
Bett, AJ
Caskey, CT
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (14) : 7866 - 7871
[48] Adenoviral gene therapy leads to rapid induction of multiple chemokines and acute neutrophil-dependent hepatic injury in vivo
Muruve, DA
Barnes, MJ
Stillman, IE
Libermann, TA
[J]. HUMAN GENE THERAPY, 1999, 10 (06) : 965 - 976
[49] A helper-dependent adenovirus vector system: Removal of helper virus by Cre-mediated excision of the viral packaging signal
Parks, RJ
Chen, L
Anton, M
Sankar, U
Rudnicki, MA
Graham, FL
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (24) : 13565 - 13570
[50] A helper-dependent system for adenovirus vector production helps define a lower limit for efficient DNA packaging
Parks, RJ
Graham, FL
[J]. JOURNAL OF VIROLOGY, 1997, 71 (04) : 3293 - 3298

← 1 2 3 4 5 6 7 →